Patz EF Jr - Search Results

1

Single nucleotide polymorphisms in FOXP1 and RORA of the lymphocyte activation-related pathway affect survival of lung cancer patients.

Du H, Mu R, Liu L, Liu H, Luo S, Patz EF Jr, Glass C, Su L, Du M, Christiani DC, Li H, Wei Q. Du H, et al. Among authors: patz ef jr. Transl Lung Cancer Res. 2022 May;11(5):890-901. doi: 10.21037/tlcr-22-104. Transl Lung Cancer Res. 2022. PMID: 35693292 Free PMC article.

2

Genetic variants in DDO and PEX5L in peroxisome-related pathways predict non-small cell lung cancer survival.

Chen AS, Liu H, Wu Y, Luo S, Patz EF Jr, Glass C, Su L, Du M, Christiani DC, Wei Q. Chen AS, et al. Among authors: patz ef jr. Mol Carcinog. 2022 Jul;61(7):619-628. doi: 10.1002/mc.23400. Epub 2022 May 3. Mol Carcinog. 2022. PMID: 35502931

3

Prognostic significance of a complement factor H autoantibody in early stage NSCLC.

Gottlin EB, Campa MJ, Gandhi R, Bushey RT, Herndon Nd JE, Patz EF Jr. Gottlin EB, et al. Among authors: patz ef jr. Cancer Biomark. 2022;34(3):385-392. doi: 10.3233/CBM-210355. Cancer Biomark. 2022. PMID: 35068447

4

Mediastinal Lymphadenopathy in the National Lung Screening Trial (NLST) Is Associated with Interval Lung Cancer.

Chalian H, McAdams HP, Lee Y, Duan F, Wu Y, Khoshpouri P, Patz EF Jr. Chalian H, et al. Among authors: patz ef jr. Radiology. 2022 Mar;302(3):684-692. doi: 10.1148/radiol.210522. Epub 2021 Nov 23. Radiology. 2022. PMID: 34812667

5

Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival.

Liu L, Liu H, Luo S, Patz EF Jr, Glass C, Su L, Lin L, Christiani DC, Wei Q. Liu L, et al. Among authors: patz ef jr. Front Oncol. 2021 Oct 6;11:717109. doi: 10.3389/fonc.2021.717109. eCollection 2021. Front Oncol. 2021. PMID: 34692492 Free PMC article.

6

Genetic Variants of CLPP and M1AP Are Associated With Risk of Non-Small Cell Lung Cancer.

Li X, Zou Y, Li T, Wong TKF, Bushey RT, Campa MJ, Gottlin EB, Liu H, Wei Q, Rodrigo A, Patz EF Jr. Li X, et al. Among authors: patz ef jr. Front Oncol. 2021 Sep 15;11:709829. doi: 10.3389/fonc.2021.709829. eCollection 2021. Front Oncol. 2021. PMID: 34604049 Free PMC article.

7

Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosis.

Bushey RT, Gottlin EB, Campa MJ, Patz EF Jr. Bushey RT, et al. Among authors: patz ef jr. PLoS One. 2021 Jun 16;16(6):e0252577. doi: 10.1371/journal.pone.0252577. eCollection 2021. PLoS One. 2021. PMID: 34133431 Free PMC article.

8

Genetic variants of DOCK2, EPHB1 and VAV2 in the natural killer cell-related pathway are associated with non-small cell lung cancer survival.

Du H, Liu L, Liu H, Luo S, Patz EF Jr, Glass C, Su L, Du M, Christiani DC, Wei Q. Du H, et al. Among authors: patz ef jr. Am J Cancer Res. 2021 May 15;11(5):2264-2277. eCollection 2021. Am J Cancer Res. 2021. PMID: 34094683 Free PMC article.

9

Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.

Mu R, Liu H, Luo S, Patz EF Jr, Glass C, Su L, Du M, Christiani DC, Jin L, Wei Q. Mu R, et al. Among authors: patz ef jr. Int J Cancer. 2021 Sep 15;149(6):1302-1312. doi: 10.1002/ijc.33702. Epub 2021 Jun 10. Int J Cancer. 2021. PMID: 34058013 Free PMC article.

10

Lung Cancer Screening with Chest CT: Efficacy Confirmed.

Tailor TD, Patz EF Jr. Tailor TD, et al. Among authors: patz ef jr. Radiol Imaging Cancer. 2020 May 29;2(3):e204015. doi: 10.1148/rycan.2020204015. eCollection 2020 May. Radiol Imaging Cancer. 2020. PMID: 33778718 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results